{"id":47000,"date":"2022-08-29T06:24:42","date_gmt":"2022-08-29T10:24:42","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=47000"},"modified":"2022-08-29T03:25:58","modified_gmt":"2022-08-29T07:25:58","slug":"the-fda-orders-pfizer-inc-nyse-pfe-to-test-another-round-of-paxlovid-on-rebound-patients","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/the-fda-orders-pfizer-inc-nyse-pfe-to-test-another-round-of-paxlovid-on-rebound-patients-47000","title":{"rendered":"The FDA Orders Pfizer Inc. (NYSE: PFE) to Test Another Round of Paxlovid on Rebound Patients"},"content":{"rendered":"

The U.S Food and Drug Administration has requested Pfizer Inc. (NYSE: PFE)<\/strong> to test another round of Paxlovid on patients experiencing rebound COVID-19 after treatment. The regulator also asked Pfizer to produce the first results from a randomisPFE<\/strong>ed controlled trial that evaluated the effects of a second oral drug dose. The regulator expects these results by September 30.<\/p>\n

The order comes after an increased number of cases where patients have recurring symptoms or viral infection after treatment with Paxlovid. While the company claims that the cases are rare, the FDA has started talks with Pfizer over the matter.<\/p>\n

The FDA has stated the need for a protocol to treat people with recurring infection<\/p>\n

It is now working with Pfizer to come up with appropriate measures.<\/p>\n

Famous cases of rebound infection<\/b><\/p>\n

The most famous case of a rebound infection was with U.S President Joe Biden. The President experienced symptoms days after he was treated with Paxlovid. Biden tested positive for seven straight days after his rebound diagnosis.<\/p>\n

Biden had initially tested positive on July 21. He was treated and then tested negative twice after his isolation. Days later, the president tested positive again and developed symptoms of COVID-19, including a cough.<\/p>\n

Another famous case for rebound COVID was with Dr Anthony Fauci, Biden\u2019s Chief Medical Adviser. Dr Fauci reports that he experienced worse symptoms after he received treatment due to his first round of infection. Fauci, who is 81 l, received Paxlovid as his age put him at risk for severe disease. He states that the drug served this purpose and protected him from severe illness.<\/p>\n

The CDC gives guidelines for rebound illness<\/b><\/p>\n

The Centre for Disease Control and Prevention advises people with rebound disease after taking Paxlovid to isolate and keep wearing masks for ten days from the reappearance of symptoms. While many still test positive after ten days, they are less likely to shed the virus.<\/p>\n

Although many people believe the rebound disease only occurs in people who takes Paxlovid, a new study indicates that anyone could experience it. The study indicates that 27% of untreated people experience rebound symptoms a month after the initial infection. However, this research isn\u2019t peer reviewed.<\/p>\n","protected":false},"excerpt":{"rendered":"

The U.S Food and Drug Administration has requested Pfizer Inc. (NYSE: PFE) to test another round of Paxlovid on patients experiencing rebound COVID-19 after treatment. […]<\/p>\n","protected":false},"author":15,"featured_media":46717,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264],"tags":[207,15819,15820,15027],"stock_ticker":[],"class_list":["post-47000","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-pfe","tag-pfe-news","tag-pfe-stock","tag-pfizer-nysepfe","entry"],"acf":[],"yoast_head":"\nThe FDA Orders Pfizer Inc. (NYSE: PFE) to Test Another Round of Paxlovid on Rebound Patients - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/the-fda-orders-pfizer-inc-nyse-pfe-to-test-another-round-of-paxlovid-on-rebound-patients-47000\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"The FDA Orders Pfizer Inc. (NYSE: PFE) to Test Another Round of Paxlovid on Rebound Patients - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"The U.S Food and Drug Administration has requested Pfizer Inc. (NYSE: PFE) to test another round of Paxlovid on patients experiencing rebound COVID-19 after treatment. […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/the-fda-orders-pfizer-inc-nyse-pfe-to-test-another-round-of-paxlovid-on-rebound-patients-47000\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2022-08-29T10:24:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2022\/06\/Capture.png\" \/>\n\t<meta property=\"og:image:width\" content=\"675\" \/>\n\t<meta property=\"og:image:height\" content=\"454\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Benjamin Roussey\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Benjamin Roussey\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/the-fda-orders-pfizer-inc-nyse-pfe-to-test-another-round-of-paxlovid-on-rebound-patients-47000#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/the-fda-orders-pfizer-inc-nyse-pfe-to-test-another-round-of-paxlovid-on-rebound-patients-47000\"},\"author\":{\"name\":\"Benjamin Roussey\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e82d48e74e653b113f0f9186826f808d\"},\"headline\":\"The FDA Orders Pfizer Inc. (NYSE: PFE) to Test Another Round of Paxlovid on Rebound Patients\",\"datePublished\":\"2022-08-29T10:24:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/the-fda-orders-pfizer-inc-nyse-pfe-to-test-another-round-of-paxlovid-on-rebound-patients-47000\"},\"wordCount\":379,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/the-fda-orders-pfizer-inc-nyse-pfe-to-test-another-round-of-paxlovid-on-rebound-patients-47000#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2022\/06\/Capture.png\",\"keywords\":[\"PFE\",\"PFE News\",\"PFE Stock\",\"Pfizer (NYSE:PFE)\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/the-fda-orders-pfizer-inc-nyse-pfe-to-test-another-round-of-paxlovid-on-rebound-patients-47000\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/the-fda-orders-pfizer-inc-nyse-pfe-to-test-another-round-of-paxlovid-on-rebound-patients-47000\",\"name\":\"The FDA Orders Pfizer Inc. (NYSE: PFE) to Test Another Round of Paxlovid on Rebound Patients - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/the-fda-orders-pfizer-inc-nyse-pfe-to-test-another-round-of-paxlovid-on-rebound-patients-47000#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/the-fda-orders-pfizer-inc-nyse-pfe-to-test-another-round-of-paxlovid-on-rebound-patients-47000#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2022\/06\/Capture.png\",\"datePublished\":\"2022-08-29T10:24:42+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/the-fda-orders-pfizer-inc-nyse-pfe-to-test-another-round-of-paxlovid-on-rebound-patients-47000#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/the-fda-orders-pfizer-inc-nyse-pfe-to-test-another-round-of-paxlovid-on-rebound-patients-47000\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/the-fda-orders-pfizer-inc-nyse-pfe-to-test-another-round-of-paxlovid-on-rebound-patients-47000#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2022\/06\/Capture.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2022\/06\/Capture.png\",\"width\":675,\"height\":454},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/the-fda-orders-pfizer-inc-nyse-pfe-to-test-another-round-of-paxlovid-on-rebound-patients-47000#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"The FDA Orders Pfizer Inc. (NYSE: PFE) to Test Another Round of Paxlovid on Rebound Patients\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e82d48e74e653b113f0f9186826f808d\",\"name\":\"Benjamin Roussey\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e051c9045b5c74768cca8f069d353d6ff45d41d241616ca1151ef20f3f86ff14?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e051c9045b5c74768cca8f069d353d6ff45d41d241616ca1151ef20f3f86ff14?s=96&d=mm&r=g\",\"caption\":\"Benjamin Roussey\"},\"description\":\"Benjamin Roussey is from Sacramento, California. He has two master\u2019s degrees and served four years in the U.S. Navy. His bachelor\u2019s degree is from CSUS (1999) where he was on a baseball pitching scholarship. His second master\u2019s degree is an MBA in Global Management from the University of Phoenix (2006). He has worked for small businesses, public agencies, and large corporations. He has lived in Korea and Saudi Arabia where he was an ESL instructor. Benjamin spends his time in between Northern California and Cabo San Lucas, Mexico, committing himself to his craft of freelance and website writing. http:\/\/www.facebook.com\/ben.rouss\",\"sameAs\":[\"https:\/\/cablemanpro.com\/wallstreetpr\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/benjamin-roussey\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"The FDA Orders Pfizer Inc. (NYSE: PFE) to Test Another Round of Paxlovid on Rebound Patients - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/the-fda-orders-pfizer-inc-nyse-pfe-to-test-another-round-of-paxlovid-on-rebound-patients-47000","og_locale":"en_US","og_type":"article","og_title":"The FDA Orders Pfizer Inc. (NYSE: PFE) to Test Another Round of Paxlovid on Rebound Patients - Wall Street PR","og_description":"The U.S Food and Drug Administration has requested Pfizer Inc. (NYSE: PFE) to test another round of Paxlovid on patients experiencing rebound COVID-19 after treatment. […]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/the-fda-orders-pfizer-inc-nyse-pfe-to-test-another-round-of-paxlovid-on-rebound-patients-47000","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2022-08-29T10:24:42+00:00","og_image":[{"width":675,"height":454,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2022\/06\/Capture.png","type":"image\/png"}],"author":"Benjamin Roussey","twitter_misc":{"Written by":"Benjamin Roussey","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/the-fda-orders-pfizer-inc-nyse-pfe-to-test-another-round-of-paxlovid-on-rebound-patients-47000#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/the-fda-orders-pfizer-inc-nyse-pfe-to-test-another-round-of-paxlovid-on-rebound-patients-47000"},"author":{"name":"Benjamin Roussey","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e82d48e74e653b113f0f9186826f808d"},"headline":"The FDA Orders Pfizer Inc. (NYSE: PFE) to Test Another Round of Paxlovid on Rebound Patients","datePublished":"2022-08-29T10:24:42+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/the-fda-orders-pfizer-inc-nyse-pfe-to-test-another-round-of-paxlovid-on-rebound-patients-47000"},"wordCount":379,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/the-fda-orders-pfizer-inc-nyse-pfe-to-test-another-round-of-paxlovid-on-rebound-patients-47000#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2022\/06\/Capture.png","keywords":["PFE","PFE News","PFE Stock","Pfizer (NYSE:PFE)"],"articleSection":["Health"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/the-fda-orders-pfizer-inc-nyse-pfe-to-test-another-round-of-paxlovid-on-rebound-patients-47000","url":"https:\/\/cablemanpro.com\/wallstreetpr\/the-fda-orders-pfizer-inc-nyse-pfe-to-test-another-round-of-paxlovid-on-rebound-patients-47000","name":"The FDA Orders Pfizer Inc. (NYSE: PFE) to Test Another Round of Paxlovid on Rebound Patients - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/the-fda-orders-pfizer-inc-nyse-pfe-to-test-another-round-of-paxlovid-on-rebound-patients-47000#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/the-fda-orders-pfizer-inc-nyse-pfe-to-test-another-round-of-paxlovid-on-rebound-patients-47000#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2022\/06\/Capture.png","datePublished":"2022-08-29T10:24:42+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/the-fda-orders-pfizer-inc-nyse-pfe-to-test-another-round-of-paxlovid-on-rebound-patients-47000#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/the-fda-orders-pfizer-inc-nyse-pfe-to-test-another-round-of-paxlovid-on-rebound-patients-47000"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/the-fda-orders-pfizer-inc-nyse-pfe-to-test-another-round-of-paxlovid-on-rebound-patients-47000#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2022\/06\/Capture.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2022\/06\/Capture.png","width":675,"height":454},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/the-fda-orders-pfizer-inc-nyse-pfe-to-test-another-round-of-paxlovid-on-rebound-patients-47000#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"The FDA Orders Pfizer Inc. (NYSE: PFE) to Test Another Round of Paxlovid on Rebound Patients"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e82d48e74e653b113f0f9186826f808d","name":"Benjamin Roussey","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/e051c9045b5c74768cca8f069d353d6ff45d41d241616ca1151ef20f3f86ff14?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e051c9045b5c74768cca8f069d353d6ff45d41d241616ca1151ef20f3f86ff14?s=96&d=mm&r=g","caption":"Benjamin Roussey"},"description":"Benjamin Roussey is from Sacramento, California. He has two master\u2019s degrees and served four years in the U.S. Navy. His bachelor\u2019s degree is from CSUS (1999) where he was on a baseball pitching scholarship. His second master\u2019s degree is an MBA in Global Management from the University of Phoenix (2006). He has worked for small businesses, public agencies, and large corporations. He has lived in Korea and Saudi Arabia where he was an ESL instructor. Benjamin spends his time in between Northern California and Cabo San Lucas, Mexico, committing himself to his craft of freelance and website writing. http:\/\/www.facebook.com\/ben.rouss","sameAs":["https:\/\/cablemanpro.com\/wallstreetpr"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/benjamin-roussey"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/47000","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/15"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=47000"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/47000\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/46717"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=47000"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=47000"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=47000"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=47000"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}